Artigo de periodico

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease (2014)

• Authors:
  • White, Harvey D.
  • Held, Claes
  • Stewart, Ralph
  • Tarka, Elizabeth
  • Brown, Rebekkah
  • Davies, Richard Y.
  • Budaj, Andrzej
  • Harrington, Robert A.
  • Steg, P. Gabriel
  • Ardissino, Diego
  • Armstrong, Paul W.
  • Avezum, Alvaro
  • Aylward, Philip E.
  • Bryce, Alfonso
  • Chen, Hong
  • Chen, Ming-Fong
  • Corbalan, Ramon
  • Dalby, Anthony J.
  • Danchin, Nicolas
  • De Winter, Robbert J.
  • Denchev, Stefan
  • Diaz, Rafael
  • Elisaf, Moses
  • Flather, Marcus D.
  • Goudev, Assen R.
  • Granger, Christopher B.
  • Grinfeld, Liliana
  • Hochman, Judith S.
  • Husted, Steen
  • Kim, Hyo-Soo
  • Koenig, Wolfgang
  • Linhart, Ales
  • Lonn, Eva
  • López-Sendón, José
  • Manolis, Athanasios J.
  • Mohler III, Emile R.
  • Nicolau, José C.
  • Pais, Prem
  • Parkhomenko, Alexander
  • Pedersen, Terje R.
  • Pella, Daniel
  • Ramos-Corrales, Marco A.
  • Ruda, Mikhail
  • Sereg, Mátyás
  • Siddique, Saulat
  • Sinnaeve, Peter
  • Smith, Peter
  • Sritara, Piyamitr
  • Swart, Henk P.
  • Sy, Rody G.
  • Teramoto, Tamio
  • Tse, Hung-Fat
  • Watson, David
  • Weaver, W. Douglas
  • Weiss, Robert
  • Viigimaa, Margus
  • Vinereanu, Dragos
  • Zhu, Junren
  • Cannon, Christopher P.
  • Wallentin, Lars
• Autor USP: NICOLAU, JOSÉ CARLOS - FM
• Unidade: FM
• DOI: 10.1056/NEJMoa1315878
• Subjects: DOENÇAS CARDIOVASCULARES (PREVENÇÃO E CONTROLE); ARTERIOSCLEROSE CORONÁRIA; FOSFOLIPASES A; REAÇÃO EM CADEIA POR POLIMERASE; BIOLOGIA MOLECULAR; ANÁLISE SEQUENCIAL
• Language: Inglês
• Imprenta:
  • Publisher place: Boston
  • Date published: 2014
• Source:
  • Título do periódico: The New England Journal of Medicine
  • ISSN: 0028-4793
  • Volume/Número/Paginação/Ano: v. 370, n. 18, p. 1702-1711, 2014

Informações sobre o DOI: 10.1056/NEJMoa1315878 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: bronze

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  WHITE, Harvey D. et al. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. The New England Journal of Medicine, v. 370, n. 18, p. 1702-1711, 2014Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa1315878. Acesso em: 24 abr. 2024.

• APA

  White, H. D., Held, C., Stewart, R., Tarka, E., Brown, R., Davies, R. Y., et al. (2014). Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. The New England Journal of Medicine, 370( 18), 1702-1711. doi:10.1056/NEJMoa1315878

• NLM

  White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease [Internet]. The New England Journal of Medicine. 2014 ; 370( 18): 1702-1711.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1056/NEJMoa1315878

• Vancouver

  White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease [Internet]. The New England Journal of Medicine. 2014 ; 370( 18): 1702-1711.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1056/NEJMoa1315878

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
• Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
• Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
• Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
• Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
• Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
• Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
• Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
• Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
• Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study